The effect of rice bran oil, an oil not commonly consumed in the United States, on plasma lipid and apolipoprotein concentrations was studied within the context of a National Cholesterol Education Panel (NCEP) Step 2 diet and compared with the effects of canola, corn, and olive oils. The study subjects were 15 middle-aged and elderly subjects (8 postmenopausal women and 7 men; age range, 44 to 78 years) with elevated low-density lipoprotein (LDL) cholesterol (C) concentrations (range, 133 to 219 mg/dL). Diets enriched in each of the test oils were consumed by each subject for 32-day periods in a double-blind fashion and were ordered in a Latin square design. All food and drink were provided by the metabolic research unit. Diet components were identical (17% of calories as protein, 53% as carbohydrate, 30% as fat [<7% as saturated fat], and 80 mg cholesterol/1000 kcal) except that two thirds of the fat in each diet was contributed by rice bran, canola, corn, or olive oil. Mean±SD plasma total cholesterol concentrations were 192±19, 194±20, 194±19, and 205±19 mg/dL, and LDL-C concentrations were 109±30, 109±26, 108±31, and 112±29 mg/dL after consumption of the rice bran, canola, corn, and olive oil-enriched diets, respectively. Plasma cholesterol and LDL-C concentrations were similar D ietary recommendations to optimize plasma lipid profiles and reduce the risk of coronary heart disease are currently focused on total fat content, the fatty acid profile, and cholesterol content of the diet. 1 -2 Although strong and consistent evidence has demonstrated that alterations in any one of these dietary components will alter plasma lipid levels, the data are highly variable among studies.
D ietary recommendations to optimize plasma
lipid profiles and reduce the risk of coronary heart disease are currently focused on total fat content, the fatty acid profile, and cholesterol content of the diet. 1 -2 Although strong and consistent evidence has demonstrated that alterations in any one of these dietary components will alter plasma lipid levels, the data are highly variable among studies. 34 Explanations for this variability include differences in characteristics of the study population (ie, age, sex, and baseline plasma lipids), experimental conditions, and and statistically indistinguishable when the subjects consumed the rice bran, canola, and corn oil-enriched diets and lower than when they consumed the olive oil-enriched diet. Concentrations of very-low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride, LDL apolipoprotein (apo) B, apoA-I, and lipoprotein(a) and the total cholesterol to high-density lipoprotein cholesterol and apoB to apoA-I ratios were not significantly different during consumption of the different vegetable oil-enriched diets. Differences observed in the fasting state were maintained in the postprandial state. These data suggest that in middle-aged and elderly subjects with moderately elevated levels of LDL-C, consumption of diets enriched in rice bran oil results in plasma lipid and apolipoprotein concentrations and predictive ratios of cardiovascular risk that are similar to those of more commonly used vegetable oils in the United States. An additional explanation may relate to variable amounts of other less wellcharacterized components in the diet or dietary fat, such as the unsaponifiable fraction, which has also been shown to affect plasma lipid concentrations. 57 Compared with other vegetable oils or oil blends of similar fatty acid composition, rice bran oil has been reported to have a hypocholesterolemic effect when fed to rodents and nonhuman primates. 8 "' 1 In some cases this diet-induced hypocholesterolemia resulted from a selective decrease in the low-density lipoprotein (LDL) cholesterol (C) fraction. 8911 In addition the hypocholesterolemic effect of rice bran oil was greater than predicted from the fatty acid composition of the oil itself. 11 This discrepancy between predicted and observed changes in plasma cholesterol levels at the end of the rice bran oil consumption period has been attributed to the oil's relatively high concentration of unsaponifiable compounds, including plant sterols, oryzanols, and tocotrienols, relative to other vegetable oils generally available for human consumption.
within the context of the current National Cholesterol Education Panel (NCEP) guidelines. The population chosen for this study was a group of older Americans, for whom recommendations to modify their diet to improve plasma lipid concentrations are most commonly made, ie, those with LDL-C concentrations ^ 130 mg/dL.
Methods Subjects
Fifteen subjects (8 female and 7 male) with a mean age of 61 years (range, 44 to 78) and LDL-C levels £130 mg/dL (range, 133 to 219) at the time of screening provided a medical history, underwent a physical examination, and had clinical chemical analyses performed before enrollment in the study. The subjects had no evidence of any chronic illness, including hepatic, renal, thyroid, or cardiac dysfunction. They did not smoke and were not taking medication known to affect plasma lipid levels (lipid-lowering drugs, /3-blockers, diuretics, or hormones). All women were postmenopausal. This protocol was approved by the Human Investigation Review Committee of New England Medical Center and Tufts University.
Experimental Design
Each subject consumed each of four experimental diets for 32 days in a double-blind fashion; the diets were ordered in a Latin square design. We have reported that plasma lipids stabilize by week 4 after consumption of fat-modified diets. 12 A rice bran oil-enriched diet was consumed before and again during the randomization period to investigate potential confounding effects of diet order with respect to the study parameters within the context of the designated 32-day study period and to assess the reproducibility of observations under the designated study conditions. Portions of these data that address different experimental questions have been published separately. 13 -15 The diets were designed to meet NCEP Step 2 guidelines and provided approximately 15% of calories as protein, 55% as carbohydrate, 30% as fat (<7% saturated fatty acids [SFAs], 10% to 15% monounsaturated fatty acids [MUFAs] , and up to 10% polyunsaturated fatty acids [PUFAs] ) and »80 mg cholesterol/1000 kcal. Two thirds of the fat in each experimental diet (20% of calories) was provided by the test oil and was incorporated into various food combinations. The oils were given letter designations, and the investigators, food service personnel, and study subjects were not aware of the letter designation code. No alcohol was incorporated into the experimental diets. Triplicate preparations of each complete meal cycle (3 days) for each diet were analyzed by Hazleton Laboratories America, Inc.
Four times during the final week of each study phase, fasting blood samples were obtained for lipid and apolipoprotein determinations. During one of these days the subjects remained in the metabolic research unit. While consuming their three meals plus one snack at standardized intervals, the study subjects donated blood samples at 0, 5, 8, 10, and 24 hours after breakfast (0 hour). Breakfast was served just after 8 AM, lunch at noon, supper at 5 PM, and a snack at 8 PM. Once during week 3 and week 5, fasting blood samples were obtained for fatty acid analysis.
All food and drink were provided by the Metabolic Research Unit of the US Department of Agriculture Human Nutrition Center on Aging at Tufts University for consumption on-site or packaged for takeout. Subjects were required to report to our metabolic research unit at least three times per week, have their body weight measured at each visit, and consume at least one meal on-site. The subjects were encouraged to maintain their habitual level of physical activity. Caloric intake was adjusted, when necessary, to maintain body weight. Mean caloric intake±SD was 2679±608 kcal (range, 2000 to 4000).
Biochemical Analysis
Fasting (14-hour) blood samples were collected in tubes containing EDTA (0.1%), and very-low-density lipoprotein was isolated from plasma by a single ultracentrifugation spin (39 000 rpm for 18 hours at 4°C). Plasma and the 1.006-g/mL infranatant were assayed for total cholesterol and/or triglycerides with an Abbott Diagnostics ABA-200 bichromatic analyzer and enzymatic reagents. 16 High-density lipoprotein (HDL)-C was measured as described. 17 Non-HDL-C (total cholesterol minus HDL-C) was determined in postprandial plasma. Lipid assays were standardized through the Lipid Standardization Program of the Centers for Disease Control and Prevention, Atlanta, Ga. Within-run and between-run coefficients of variation of these assays were <2% for cholesterol and <2.5% for triglycerides.
LDL apolipoprotein (apo) B within the 1.006-g/mL infranatant fraction was assayed with a noncompetitive, enzymelinked assay and immunopurified polyclonal antibodies. 18 Plasma apoA-I was assayed in the same manner with apoA-I polyclonal antibodies. Coefficients of variation for both assays were <5% within runs and <10% between runs. Assays were standardized with LDL containing only apoB and purified apoA-I, with the protein content determined by amino acid analysis. Lipoprotein(a) (Lp[a]) was quantitated with an enzyme-linked assay and a monoclonal antibody as the first antibody that did not cross-react with plasminogen and a polyclonal antibody as the second antibody directed against the apo(a) portion of the Lp(a) particle (Terumo Medical Corp). Lp(a) concentrations are expressed as total Lp(a) mass (in milligrams per deciliter). 19 Fatty acid methyl esters (FAMEs) were prepared from plasma lipid extracts as described. 20 FAMEs were analyzed on a Hewlett-Packard 5890 gas-liquid chromatograph fitted with a 105-m fused-silica capillary column with liquid-phase RTX 2330 (Restek Corp) and detected with a flame ionization detector as described. 21 Peak identification was validated by chromatography of mixtures of authenticated FAMEs. Fatty acid profiles of the dietary oils were determined as described. 22 Plant sterols were quantitated as described. 23 Briefly, the oils were saponified and the sterols extracted into hexane for analysis on a Varian 6000 gas-liquid chromatograph fitted with a 10-ft packed column (1% OV210 and 2% SE-30 phases) and a flame ionization detector. Tocols and y-oryzanol components were quantitated as described. 24 
Statistical Analysis
Data were analyzed by using SAS software (Statistical Analysis System) for a personal computer and a VAX mainframe. 25 ANOVA was performed by PROC GLM. When the main effects were significant (P<.05), Dunnett's / test for multiple comparisons was used to compare the rice bran oil data with those of every other test diet. Tukey's / test was used to compare time effects by using all possible comparisons.
Results
Characteristics of the study subjects are summarized in Table 1 . The primary selection criterion for the study subjects was an LDL-C concentration 2: 130 mg/dL; the actual mean±SD LDL-C concentration at screening was 163±22 mg/dL. Two subjects lost significant amounts of weight (7 and 10 kg) between screening and the start of the study period, which resulted in decreases in their LDL-C concentrations. Mean age±SD of the study subjects was 61 ±13 years, and as a group the subjects had a somewhat elevated mean body mass index, a characteristic of older subjects with moderately elevated plasma lipid concentrations. Other plasma lipid characteristics were unremarkable and within the 10th to 90th percentile for age and sex norms. 26 Fatty acid profiles and plant sterol components of each of the four experimental oils are shown in Tables  2 and 3 . Rice bran oil had a higher proportion of SFAs, specifically palmitic acid (16:0), than the other vegetable oils (Table 2) . Rice bran oil contained modest proportions of MUFAs and PUFAs, the percent distributions of which were intermediate between olive/ canola oils and corn oil. Canola and olive oils were relatively high in MUFAs, whereas corn oil was relatively high in PUFAs. Table 3 shows the major plant sterols in the four vegetable oils. Rice bran oil contained approximately 2 to 12 times the concentration of campesterol, stigmasterol, and /3-sitosterol as the other three vegetable oils. Therefore, on the basis of average calorie intake (2700 kcal), the intake of /3-sitosterol, the major plant sterol in rice bran oil, was 755, 209, 393, and 64 mg/d, for the rice bran, canola, corn, and olive oil-enriched diets, respectively. In addition, rice bran oil contained 49 mg/100 g of tocotrienols and 51 mg/100 g of -y-oryzanol. These compounds were undetectable in the other three oils.
Analytic data on the composition, fatty acid profile, and cholesterol content of the complete diets as consumed by the subjects are shown in Table 4 . As anticipated from the design of the diets, the protein, carbohydrate, and fat contents of the four diets were essentially identical. In addition, there was good agreement between the calculated target and analytic values for the nutrients. Differences in the fatty acid content of the vegetable oils were somewhat moderated after incorporation into the diets. The rice bran oil-enriched diet had a relatively high percentage of calories from SFAs and a moderate amount from MUFAs, higher than those found in the corn oil-enriched diet but lower than those in the canola and olive oil-enriched diets. The percentage of PUFAs in the rice bran oil-enriched diet was again moderate, lower than that in the corn oil-enriched diet but higher than those in the canola and olive oil-enriched diets.
Plasma fatty acids patterns were assessed to confirm dietary compliance (Table 5 ). Because the data for plasma fatty acids determined during weeks 3 and 5 of each study period were not statistically different (data not shown), mean values are presented. Consumption of each experimental diet resulted in a characteristic plasma fatty acid profile that to a certain extent reflected that of the diet. The plasma fatty acid pattern during consumption of the rice bran oil-enriched diet with respect to the percent distribution of SFAs, MUFAs, and PUFAs was intermediate to the other three oils. Consumption of the olive oil-enriched diet resulted in the highest relative proportion of oleic acid (18:ln9) in the plasma of all study subjects. Consumption of the canola oil-enriched diet resulted in a relatively high proportion of oleic acid (18:ln9) as well as a strikingly high proportion of o-linolenic acid (18:3n3). Plasma obtained from subjects during consumption of the corn oil-enriched diet was relatively high in linoleic acid (18:2n6) and low in oleic acid All study subjects consumed the diet enriched in rice bran oil twice, once during a time determined by each individual randomization scheme and once before the start of the randomized phases; the duplicate rice bran oil phases provided data on reproducibility of the experimental results when confounded by the effect of diet order. Mean (±SD) total plasma cholesterol, non-HDL-C, and HDL-C concentrations at the end of the two rice bran oil-enriched diet phases were 193±18, 150±23, and 43±9 mg/dL and 192±19, 148±22, and 44 ±9 mg/dL, respectively. These data suggest that the order in which the diets were consumed did not significantly affect the results and that the data are reproducible.
Consumption of the rice bran oil-enriched diet resulted in plasma total cholesterol concentrations that were similar to those in the periods when the subjects consumed the canola and corn oil-enriched diets. Total cholesterol concentrations during these periods were significantly lower than when the subjects consumed the olive oil-enriched diet (Table 6 and Fig 1) . The same trend was seen for LDL-C concentrations: values were similar when the subjects consumed the rice bran, canola, and corn oil enriched-diets and slightly but significantly higher when the subjects consumed the olive oil-enriched diet. There were no significant differences in the concentrations of plasma VLDL-C, HDL-C, triglyceride, LDL apoB, apoA-I, and Lp(a) or in the ratios of total cholesterol to HDL-C and LDL apoB to apoA-I while the subjects consumed the different experimental diets.
Postprandial plasma lipid concentrations were assessed three times during a 24-hour period at the end of each diet phase while the subjects consumed their three meals plus one snack. The differences observed in the fasting state (hours 0 and 24) for plasma total cholesterol and LDL-C were also observed for the postprandial state (Table 7) ; ie, plasma concentrations of total cholesterol and non-HDL-C at hours 5, 8, and 10 were significantly higher when the subjects consumed the olive oil-enriched diet relative to the canola, corn, and rice bran oil-enriched diets. Plasma trigfyceride concentrations were higher in postprandial than fasting blood samples after consumption of all diets tested. There were no significant differences in the magnitude of these increases among the canola, corn, olive, or rice bran oil-enriched diets. For all diets tested there was a significant decrease in HDL-C concentration in the postprandial state. Again, the magnitude of these decreases was similar for all diets tested.
Discussion
Within the context of current dietary guidelines, ie, <30% of calories as fat and <7% as SFA, attention has been focused on diet optimization that maximizes decreases in LDL-C and minimizes decreases in HDL-C concentrations. Although little is known about the effects of rice bran oil consumption on plasma lipids, a few intriguing reports are available. The intent of this investigation was to assess the effects of consuming diets enriched in rice bran oil on plasma lipids compared with other vegetable oils that are relatively high in MUFAs and PUFAs and that are more commonly consumed in the United States in a group of subjects with moderately elevated plasma lipids and within the context of current guidelines for that group. The data indicate that consumption of a rice bran oil-enriched diet results in plasma lipid responses similar to those of canola and corn oil-enriched diets.
In rats consumption of rice bran oil relative to groundnut (peanut) oil has been reported to lower total cholesterol and trigryceride and to raise HDL-C concentrations. 8 -9 In hamsters addition of rice bran oil or rice bran plus rice bran oil to semipurified diets has been reported to decrease plasma total cholesterol levels relative to diets supplemented with cellulose. 10 Results of a well-controlled study in nonhuman primates have suggested that rice bran oil, despite its unfavorable SFA profile, relative to other oils or oil blends tested resulted in significant reductions in total VLDL-C Indicates very-low-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; apo, apcHipoprotein; TC/HDL-C, ratio of total cholesterol to HDL-C. Values are mean±SD and are In milligrams per deciliter; n=15. An ANOVA to test for diet effects was carried out at a significance level of P=.O5. When ANOVA was significant a Dunnett's t test for multiple comparisons with the rice bran oil-enriched diet was carried out at +P=.01 and + P=.001. cholesterol and LDL-C without affecting HDL-C concentrations. 11 In a recent study in nonhuman primates, addition of rice bran oil to a diet at a level similar to that in the current study resulted in significant reductions in total cholesterol and LDL-C concentrations relative to a baseline diet and had an advantage in terms of minimizing decreases in HDL-C compared with several other vegetable oil-enriched diets. 27 Less is known about the effects of rice bran oil consumption on plasma lipids in humans. Raghuram et al 28 reported that substitution of rice bran oil for various amounts and combinations of palm, groundnut, and/or coconut oil resulted in significant reductions in total cholesterol and triglyceride concentrations. Given the limited information on the effect of groundnut oil on plasma lipids in humans and the high SFA content of palm and coconut oils, few conclusions can be drawn from this study with respect to rice bran oil.
The earlier literature is replete with reports suggesting that consumption of plant sterols can lower plasma lipid concentrations.
5 -7 -29 - 31 The efficacy of different plant sterols has been reported to vary, depending on their chemical structure and the actual quantities consumed.
32
* 33 The hypocholesterolemic effects of plant sterols, which are structurally similar to cholesterol, have been attributed in part to effects on cholesterol absorption. 32 -33 The mechanisms include the ability of plant sterols to displace cholesterol within intestinal micelles, decrease binding of cholesterol to the brush border membranes, decrease intracellular esterification of cholesterol, and decrease incorporation of cholesterol into chylomicrons. 3141 However, these effects were observed only when quantities in excess of those obtainable from naturally occurring oils were consumed.
Tocotrienols and oryzanols, components of the unsaponifiable fraction of some vegetable oils, have also been reported to decrease plasma lipid concentrations. 3537 Tocotrienols, analogues of tocopherol with unsaturated side chains that have some vitamin E biological activity, have been reported to inhibit hepatic hydroxymethylglutaryl coenzyme A reductase, the ratelimiting enzyme in cholesterol biosynthesis. 38 Oryzanol and ferulic acid esters of plant sterols, such as triterpene alcohols and 4-methyl sterols, have been reported to exert a hypocholesterolemic effect by decreasing cholesterol absorption and inhibiting hepatic cholesterol synthesis. 39 " 41 It is difficult to assess the independent effects of these factors relative to differences in the fatty acid composition of the oils in the current study.
In this group of individuals, plasma lipid levels were lowest when the subjects consumed canola, corn, and rice bran oil-enriched diets relative to the olive oilenriched diet. The intent of this study was to assess the effects of commonly consumed oils relative to rice bran oil. For this reason the oils were single lots of commercially available products with fatty acid compositions and sterol contents as characterized and presented. Other sources or lots of oil may differ in both the nontriglyceride and triglyceride fractions. Additionally, although the study subjects were candidates for dietary HDL-C indicates high-density lipoproteln cholesterol; non-HDL-C, total cholesterol minus HDL-C. Values are mean±SD and are in milligrams per deciliter; n=15. A one-way ANOVA to determine the effect of diet on each variable at each time was performed. If significant, a Dunnett's r test for multiple comparisons was carried out at ||P<.01, and V<.001 using rice bran oil as the diet of comparison. A three-way ANOVA with main effects of hours postprandial, diet, and subject was carried out to evaluate changes in these variables. Averaged over all diets, there were no time effects on total cholesterol. Non-HDL-C showed a significant time effect at P=.O26, and triglyceride and HDL-C were significant at P<.001. Tukey's f test for multiple comparisons showed no significant effects within non-HDL-C. Results of Tukey's f test for HDL-C and triglyceride are given as symbols on the hours under each variable. Values without a common symbol are significantly different at P<.05. modification on the basis of their plasma lipid concentrations, the least is known about the relative responsiveness of this group to dietary modification compared with younger, normocholesterolemic subjects.
A decrease in postprandial HDL-C concentration was observed as a result of consuming all of the vegetable oil-enriched diets in the current study. The decrease was inversely associated with but preceded by changes in plasma trigrycerides, as has been observed after a single fat load 4245 and that has been attributed to trigryceride-rich lipoprotein metabolism.
No differences with respect to sex were observed in this study, possibly because of the lack of statistical power to investigate this factor specifically. All women in this study were postmenopausal. We cannot determine whether similar results would have been observed in premenopausal females. However, postmenopausal women are more likely to have elevated LDL-C levels and, hence, to be candidates for diet therapy.
From this study we conclude that consumption of a diet enriched in rice bran oil, a relatively uncommon dietary oil in the United States, or corn or canola oil within the context of current NCEP guidelines has comparable advantages in terms of lowering plasma lipid levels or improving the cardiovascular risk profile. Because consumption of the rice bran oil-enriched diet did result in a greater reduction in plasma total cholesterol than was expected from predicted calculations, 46 -47 perhaps some component of rice bran oil, possibly in the unsaponifiable fraction, may have exerted a greater effect on plasma cholesterol relative to other vegetable oils than can be ascribed to the fatty acid composition of the oil itself.
